Cargando…
Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site
PURPOSE: The purpose of the present study was to investigate risk factors for esophageal fistula (EF) in patients with recurrent esophageal cancer receiving re-radiotherapy with or without chemotherapy. METHODS: We reviewed retrospectively the clinical characters and dosimetric parameters of 96 pati...
Autores principales: | Wang, Xinran, Hu, Bing, Chen, Jinhu, Xie, Feihong, Han, Dan, Zhao, Qian, Sun, Hongfu, Fu, Chengrui, Liu, Chengxin, Wang, Zhongtang, Lin, Haiqun, Huang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876373/ https://www.ncbi.nlm.nih.gov/pubmed/35209855 http://dx.doi.org/10.1186/s12885-022-09319-4 |
Ejemplares similares
-
Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study
por: Liu, Chengxin, et al.
Publicado: (2023) -
Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis
por: Dong, Jinling, et al.
Publicado: (2021) -
Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
por: Takeda, Kazuya, et al.
Publicado: (2021) -
Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma
por: Hu, Bing, et al.
Publicado: (2020) -
Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)